SCHEMBL30166807

SCHEMBL30166807

O=C1[C@@H](C2CC2)[C@@H](c2c(F)cc(C3CC3)cc2F)N1c1ccc2[nH]cnc2c1

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ QPCT Q16769 20/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25709838 1.00 QPCT (0.42) QPCT
SCHEMBL30166839 1.00 QPCT (0.42) QPCT
SCHEMBL24814412 1.00 QPCT (0.42) QPCT
SCHEMBL24816692 1.00 QPCT (0.42) QPCT
SCHEMBL25709844 1.00 QPCT (0.42) QPCT
SCHEMBL24813902 1.00 QPCT (0.42) QPCT
SCHEMBL24815428 0.89 QPCT (0.44) QPCT
SCHEMBL30166888 0.89 QPCT (0.44) QPCT
SCHEMBL24815417 0.89 QPCT (0.44) QPCT
SCHEMBL30166838 0.89 QPCT (0.44) QPCT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118019737-A Beta-lactam derivatives for the treatment of diseases 英矽智能科技知识产权有限公司 2024-05-10 — — CN disclosed
EP-4359405-A1 BETA-LACTAM DERIVATIVES FOR THE TREATMENT OF DISEASES Insilico Medicine IP Limited (HK) 2024-05-01 — — EP disclosed
WO-2022268179-A1 BETA-LACTAM DERIVATIVES FOR THE TREATMENT OF DISEASES INSILICO MEDICINE IP LIMITED (CN) 2022-12-29 — — WO disclosed
Send feedback